Oscar Health, Inc. (NYSE:OSCR) Given Average Rating of “Hold” by Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCRGet Free Report) have earned a consensus rating of “Hold” from the eight research firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $20.21.

A number of research firms have recently issued reports on OSCR. Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Jefferies Financial Group initiated coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price on the stock.

Read Our Latest Stock Analysis on OSCR

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of OSCR. Vanguard Group Inc. boosted its stake in Oscar Health by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company’s stock valued at $255,333,000 after acquiring an additional 586,626 shares in the last quarter. Deerfield Management Company L.P. Series C increased its position in shares of Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock valued at $159,062,000 after acquiring an additional 3,983,325 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock valued at $139,246,000 after purchasing an additional 8,051,379 shares during the period. Thrive Capital Management LLC lifted its holdings in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the period. Finally, Gilder Gagnon Howe & Co. LLC boosted its position in Oscar Health by 51.4% in the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock valued at $85,154,000 after buying an additional 2,151,256 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Price Performance

Oscar Health stock opened at $12.97 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market cap of $3.25 billion, a price-to-earnings ratio of -648.28 and a beta of 1.75. The firm has a 50-day moving average of $14.79 and a two-hundred day moving average of $15.94. Oscar Health has a 1 year low of $12.43 and a 1 year high of $23.79.

Oscar Health (NYSE:OSCRGet Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, research analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.

About Oscar Health

(Get Free Report

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

See Also

Analyst Recommendations for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.